Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |